Continue Reading Post >

Latest Tweets

$ATBPF $ATE.v @AntibeThera Daniel Legault, CEO and Director of Antibe Therapeutics: More Licensing ...… https://t.co/f6GBWb8K8w
23rd May, 2018
"...But they added that if a standard dose of #NSAID is insufficient, a "multimodal approach" involving an NSAID, a… https://t.co/cACLSB0asD
21st May, 2018
Antibe Therapeutics is trying to change the game of non-steroidal anti-inflammatory drugs ( #NSAID )—the “largest c… https://t.co/z5jMvsJuml
20th May, 2018
$ATBPF $ATE.v Antibe Therapeutics Looking for More Licensing Deals #NSAID #Biotech @AntibeThera https://t.co/MabEe9zY11
18th May, 2018